Look behind the lecture: an industry perspective on real-world evidence

Written by The Evidence Base

In this feature, Jefferson Tea (Takeda Canada Inc., ON, Canada) discusses his presentation from the Patient Registries, Real-World Evidence and HEOR meeting (27—28 January 2020; Miami, FL, USA) on how and why the industry perception of real-world evidence may differ from that of other stakeholders. Please could you introduce yourself, your work and organization? I am the Vice President of Medical and Scientific Affairs at Takeda Canada Inc. (ON, Canada), where I lead a department consisting of teams in medical affairs, evidence generation, real-world evidence, regulatory, medical information/pharmacovigilance and quality assurance. Takeda is a global, values-based, R&D-driven biopharmaceutical leader, focused...

To view this content, please register now for access

It's completely free